One-pot Synthesis and Crystal Structure of （1S,2R,3S,4R,5S）-1-Phenyl-2,4-dibenzoyl-3,5-difurylhexanol

(1S,2R,3S,4R,5S)-1-Phenyl-2,4-dibenzoyl-3,5-difurylhexanol 1 was synthesized by one-pot reaction of hypnone and furfurol in alkali H2O/EtOH solution and structurally defined to contain a chair-formed aliphatic carbocycle, on which the bulky substituents occupy the equatorial positions.     

A novel alkaline earth strontium(II) coordination polymer: poly[hexaaquatetrakis(μ5‐pyridine‐2,6‐dicarboxylato)bis(μ4‐pyridine‐2,6‐dicarboxylato)(μ7‐sulfato)heptastrontium(II)]

The title compound, [Sr₇(C₇H₃NO₄)₆(SO₄)(H₂O)₆]_n, has been synthesized by an ionothermal method using the ionic liquid 1‐ethyl‐3‐methylimidazolium ([Emim]Br) as solvent, and characterized by elemental analysis, energy‐dispersive X‐ray spectroscopy, IR and single‐crystal X‐ray diffraction. The structure of the compound can be viewed as a three‐dimensional coordination polymer composed of Sr²⁺ cations, pyridine‐2,6‐dicarboxylate anions, sulfate anions and water molecules. The compound not only exhibits a three‐dimensional structure with a unique coordination mode of the sulfate anion, but also features the first example of a heptanuclear strontium(II) coordination polymer. The structure is further stabilized by O—H...O hydrogen bonds and π–π stacking interactions.     

The antioxidant methyl 3‐(3,5‐di‐tert‐butyl‐4‐hydroxyphenyl)propionate

The title compound, C₁₈H₂₈O₃, was prepared by the reaction of 2,6‐di‐tert‐butylphenol with methyl acrylate under basic conditions using dimethyl sulfoxide as the promoter. The structure of this antioxidant indicates significant strain between the ortho tert‐butyl substituents and the phenolic OH group. In spite of the steric crowding of the OH group, it participates in intermolecular hydrogen bonding with the ester carbonyl O atom.     

Packing forces in dichloridobis(3,5‐diphenyl‐1H‐pyrazole‐κN2)cobalt(II) dichloromethane hemisolvate

The title compound, [CoCl₂(C₁₅H₁₂N₂)₂]·0.5CH₂Cl₂, was crystallized from a binary mixture of dichloromethane and hexane and a dimeric supramolecular structure was isolated. The Co^II centre exhibits a distorted tetrahedral geometry, with two independent pyrazole‐based ligands occupying two coordination sites and two chloride ligands occupying the third and fourth coordination sites. The supramolecular structure is supported by complementary hydrogen bonding between the pyrazole NH group and the chloride ligand of an adjacent molecule. This hydrogen‐bonding motif yields a ten‐membered hydrogen‐bonded ring. Density functional theory (DFT) simulations at the PBE/6‐311G level of theory were used to probe the solid‐state structure. These simulations suggest that the chelate undergoes a degree of conformational distortion from the lowest‐energy geometry to allow for optimal hydrogen bonding in the solid state.     

Diastereoisomeric forms of 11‐ethyl‐6,11‐dihydro‐5H‐dibenzo[b,e]azepine‐6‐carboxamide: syntheses and the molecular and supramolecular structure of the minor form (6RS,11RS)‐11‐ethyl‐6,11‐dihydro‐5H‐dibenzo[b,e]azepine‐6‐carboxamide

Compounds containing the tricyclic dibenzo[b,e]azepine system have potential activity in the treatment of a number of diseases. Continuing with our studies on the synthesis of new small and potentially bioactive molecules, a synthetic route, involving acid‐catalysed intramolecular Friedel–Crafts cyclization, to the readily separable diastereoisomers of 11‐ethyl‐6,11‐dihydro‐5H‐dibenzo[b,e]azepine‐6‐carboxamide, a potentially useful precursor in the synthesis of analogues of some anti‐allergenic, antidepressant and antihistaminic drugs currently in use, has been developed starting from 2‐allylphenylamine and methyl 2‐bromo‐2‐phenylacetate and proceeding via racemic methyl 2‐[(2‐allylphenyl)amino]‐2‐phenylacetate (A) and racemic 2‐[(2‐allylphenyl)amino]‐2‐phenylacetamide (B), to give the two diastereoisomers (I) and (II), C₁₇H₁₈N₂O. Isomers (I) and (II), and their precursors (A) and (B), have all been fully characterized spectroscopically. Structure analysis of the minor isomer (I) shows that it has the (6RS,11RS) configuration, and that the azepine ring adopts a conformation intermediate between the boat and twist‐boat forms, with the carboxamide and ethyl substituents both occupying quasi‐equatorial sites. The molecules of (I) are linked by a combination of N—H…O, N—H…π(arene) and C—H…π(arene) hydrogen bonds to form complex sheets. Comparisons are made with the structures of some related compounds.     

(5RS)‐5‐(4‐Methoxyphenyl)‐2‐(methylsulfanyl)benzo[g]pyrimido[4,5‐b]quinoline‐4,6,11(3H,5H,12H)‐trione,with Z′ = 3, forms a three‐dimensional hydrogen‐bonded framework containing five types of hydrogen bond

The title compound, C₂₃H₁₇N₃O₄S, crystallizes with Z′ = 3 in the space group P. Two of the three independent molecules are broadly similar in terms of both their molecular conformations and their participation in hydrogen bonds, but the third molecule differs from the other two in both of these respects. The molecules are linked by a combination of N—H...O, N—H...N, C—H...O, C—H...N and C—H...π(arene) hydrogen bonds to form a continuous three‐dimensional framework structure within which a centrosymmetric six‐molecule aggregate can be identified as a key structural element.     

Conformational study of (Z)‐5‐(4‐chlorobenzylidene)‐2‐[4‐(2‐hydroxyethyl)piperazin‐1‐yl]‐3H‐imidazol‐4(5H)‐one in different environments: insight into the structural properties of bacterial efflux pump inhibitors

The 2‐amine derivatives of 5‐arylidene‐3H‐imidazol‐4(5H )‐one are a new class of bacterial efflux pump inhibitors, the chemical compounds that are able to restore antibiotic efficacy against multidrug resistant bacteria. 5‐Arylidene‐3H‐imidazol‐4(5H )‐ones with a piperazine ring at position 2 reverse the mechanisms of multidrug resistance (MDR) of the particularly dangerous Gram‐negative bacteria E. coli by inhibition of the efflux pump AcrA/AcrB/TolC (a main multidrug resistance mechanism in Gram‐negative bacteria, consisting of a membrane fusion protein, AcrA, a Resistant‐Nodulation‐Division protein, AcrB, and an outer membrane factor, TolC). In order to study the influence of the environment on the conformation of (Z )‐5‐(4‐chlorobenzylidene)‐2‐[4‐(2‐hydroxyethyl)piperazin‐1‐yl]‐3H‐imidazol‐4(5H )‐one, ( 3 ), two different salts were prepared, namely with picolinic acid {systematic name: 4‐[(Z )‐4‐(4‐chlorobenzylidene)‐5‐oxo‐3,4‐dihydro‐1H‐imidazol‐2‐yl]‐1‐(2‐hydroxyethyl)piperazin‐1‐ium pyridine‐2‐carboxylate, C₁₆H₂₀ClN₄O₂⁺·C₆H₄NO₂⁻, ( 3 a )} and 4‐nitrophenylacetic acid {systematic name: 4‐[(Z )‐4‐(4‐chlorobenzylidene)‐5‐oxo‐3,4‐dihydro‐1H‐imidazol‐2‐yl]‐1‐(2‐hydroxyethyl)piperazin‐1‐ium 2‐(4‐nitrophenyl)acetate, C₁₆H₂₀ClN₄O₂⁺·C₈H₆NO₄⁻, ( 3 b )}. The crystal structures of the new salts were determined by X‐ray diffraction. In both crystal structures, the molecule of ( 3 ) is protonated at an N atom of the piperazine ring by proton transfer from the corresponding acid. The carboxylate group of picolinate engages in hydrogen bonds with three molecules of the cation of ( 3 ), whereas the carboxylate group of 4‐nitrophenylacetate engages in hydrogen bonds with only two molecules of ( 3 ). As a consequence of these interactions, different orientations of the hydroxyethyl group of ( 3 ) are observed. The crystal structures are additionally stabilized by both C—H…N [in ( 3 a )] and C—H…O [in ( 3 a ) and ( 3 b )] intermolecular interactions. The geometry of the imidazolone fragment was compared with other crystal structures possessing this moiety. The tautomer observed in the crystal structures presented here, namely 3H‐imidazol‐4(5H )‐one [systematic name: 1H‐imidazol‐5(4H )‐one], is also that most frequently observed in other structures containing this heterocycle.     

Hydrogen‐bonding patterns in bis[2,4,6‐triazaniumylcyclohexane‐1,3,5‐tris(olate)‐κ3O,O′,O′′]germanium(IV) tetrachloride hexahydrate

A first preliminary report on the crystal structure of a hydrated salt formulated as [Ge(taci)₂]Cl₄·13H₂O (taci is 1,3,5‐triamino‐1,3,5‐trideoxy‐cis‐inositol) appeared more than 20 years ago [Ghisletta (1994). PhD thesis, ETH Zürich. Switzerland]. At that time it was not possible to discriminate unambiguously between the positions of some of the chloride ions and water O atoms, and disorder was thus postulated. In a new determination, a conclusive scheme of hydrogen bonding proves to be a particularly appealing aspect of the structure. Single crystals of the title compound, C₁₂H₃₀GeN₆O₆⁴⁺·4Cl⁻·6H₂O or [Ge(taci)₂]₂Cl₈·12H₂O, were grown from an aqueous solution by slow evaporation of the solvent. The two [Ge(taci)₂]⁴⁺ cations exhibit a double‐adamantane‐type structure with exclusive O‐atom coordination and approximate D_3d symmetry. The taci ligands adopt a zwitterionic form with deprotonated hydroxy groups and protonated amino groups. Both cations are hydrogen bonded to six water molecules. The structure of the hydration shell of the two cations is, however, slightly different. The {[Ge(taci)₂]·6H₂O}⁴⁺ aggregates are interlinked in all three dimensions by further hydrogen bonds of the types N—H...Cl...H—N, N—H...O(H)₂...H—N, (Ge)O...H—O(H)...H—N, N—H...O(H)—H...Cl...H—N, (Ge)O...H—O—H...Cl...H—N, N—H...O(H)—H...Cl...H—(H)O...H—N, (Ge)O...H—O—H...Cl...H—(H)O...H—N and Ge(O)...H—O—H...Cl...H—O—H...O(Ge).     

Concomitant polymorphs of 1,3‐bis(3‐fluorophenyl)urea

Hydrogen bonding between urea functionalities is a common structural motif employed in crystal‐engineering studies. Crystallization of 1,3‐bis(3‐fluorophenyl)urea, C₁₃H₁₀F₂N₂O, from many solvents yielded concomitant mixtures of at least two polymorphs. In the monoclinic form, one‐dimensional chains of hydrogen‐bonded urea molecules align in an antiparallel orientation, as is typical of many diphenylureas. In the orthorhombic form, one‐dimensional chains of hydrogen‐bonded urea molecules have a parallel orientation rarely observed in symmetrically substituted diphenylureas.     

Hydrogen‐bonded bilayers in 7‐benzyl‐3‐tert‐butyl‐1‐phenyl‐4,5,6,7‐tetrahydro‐1H‐spiro[pyrazolo[3,4‐b]pyridine‐5,2′‐indan]‐1′,3′‐dione

In the title compound, C₃₁H₂₉N₃O₂, the reduced pyridine ring adopts a conformation intermediate between the envelope and half‐chair forms. The aryl rings of the benzyl and phenyl substituents are nearly parallel and overlap, indicative of an intramolecular π–π stacking interaction. A combination of two C—H...O hydrogen bonds and one C—H...N hydrogen bond links the molecules into a bilayer having tert‐butyl groups on both faces.<!?tpb=19.5pt>     

N—H...O,O—H...O hydrogen‐bonded supramolecular sheet formation in the bis(2‐aminoanilinium) fumarate, 3‐methylanilinium hydrogen fumarate and 4‐chloroanilinium hydrogen fumarate salts

In bis(2‐aminoanilinum) fumarate, 2C₆H₉N₂⁺·C₄H₂O₄²⁻, (I), the asymmetric unit consists of two aminoanilinium cations and one fumarate dianion, whereas in 3‐methylanilinium hydrogen fumarate, C₇H₁₀N⁺·C₄H₃O₄⁻, (II), and 4‐chloroanilinium hydrogen fumarate, C₆H₇ClN⁺·C₄H₃O₄⁻, (III), the asymmetric unit contains two symmetry‐independent hydrogen fumate anions and anilinium cations with a slight difference in their geometric parameters; the two salts are isostructural. In (II) and (III), the carboxylic acid H atoms of the anions are disordered across both ends of the anion, with equal site occupancies of 0.50. Both the 4‐chloroanilinium cations of (III) are disordered over two orientations with major occupancies fixed at 0.60 in each case. The hydrogen fumarate anions of (II) and (III) form one‐dimensional anionic chains linked through O—H...O hydrogen bonds. Salts (II) and (III) form two‐dimensional supramolecular sheets built from R₄⁴(16), R₄⁴(18), R₅⁵(25) and C₂²(14) motifs extending parallel to the (010) plane, whereas in (I), an (010) sheet is formed built from two R₄³(13) motifs, two R₂²(9) motifs and an R₄⁴(18) motif.     

The bimolecular structure of aquahexa‐μ‐chlorido‐μ4‐oxido‐tris(tetrahydrofuran‐κO)tetracopper(II)–hexa‐μ‐chlorido‐μ4‐oxido‐tetrakis(tetrahydrofuran‐κO)tetracopper(II)–tetrahydrofuran (2/1/4)

The title bimolecular structure, [Cu₄Cl₆O(C₄H₈O)₃(H₂O)]₂[Cu₄Cl₆O(C₄H₈O)₄]·4C₄H₈O, at 100 K has monoclinic (P2₁/c) symmetry. The structure contains nine symmetry‐independent molecules expressed in simplest molecular form as 6[Cu₄Cl₆O(C₄H₈O)₃(H₂O)·2(C₄H₈O)]:3Cu₄Cl₆O(C₄H₈O)₄. The compound exhibits a supercell (smaller than the unit cell based on weak reflections) structure due to pseudotranslational symmetry. The structure displays O—H...O hydrogen bonding between bound water ligands and tetrahydrofuran (THF) solvent molecules. The structure exhibits disorder for 12 of the THF molecules, of which seven are ligated to Cu and five are hydrogen bonded to H₂O ligands.     

Different molecular conformations co‐exist in each of three 2‐aryl‐N‐(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)acetamides: hydrogen bonding in zero,one and two dimensions

4‐Antipyrine [4‐amino‐1,5‐dimethyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐one] and its derivatives exhibit a range of biological activities, including analgesic, antibacterial and anti‐inflammatory, and new examples are always of potential interest and value. 2‐(4‐Chlorophenyl)‐N‐(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)acetamide, C₁₉H₁₈ClN₃O₂, (I), crystallizes with Z′ = 2 in the space group P, whereas its positional isomer 2‐(2‐chlorophenyl)‐N‐(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)acetamide, (II), crystallizes with Z′ = 1 in the space group C2/c; the molecules of (II) are disordered over two sets of atomic sites having occupancies of 0.6020 (18) and 0.3980 (18). The two independent molecules of (I) adopt different molecular conformations, as do the two disorder components in (II), where the 2‐chlorophenyl substituents adopt different orientations. The molecules of (I) are linked by a combination of N—H…O and C—H…O hydrogen bonds to form centrosymmetric four‐molecule aggregates, while those of (II) are linked by the same types of hydrogen bonds forming sheets. The related compound N‐(1,5‐dimethyl‐3‐oxo‐2‐phenyl‐2,3‐dihydro‐1H‐pyrazol‐4‐yl)‐2‐(3‐methoxyphenyl)acetamide, C₂₀H₂₁N₃O₃, (III), is isomorphous with (I) but not strictly isostructural; again the two independent molecules adopt different molecular conformations, and the molecules are linked by N—H…O and C—H…O hydrogen bonds to form ribbons. Comparisons are made with some related structures, indicating that a hydrogen‐bonded R₂²(10) ring is the common structural motif.     

Crystallographic report: Bis{µ‐[O‐cyclopentyl(4‐methoxyphenyl)dithiophosphonato]1κ:S,2κ:S‐[O‐cyclopentyl(4‐methoxyphenyl)dithiophosphonato]‐1κ2S,S′}dicadmium(II)

The centrosymmetric title compound, [Cd₂{CH₃OC₆H₄P(OC₅H₉)S₂}₄], features an eight‐membered [? Cd? S? P? S? ]₂ ring owing to the presence of bridging dithiolate ligands. Tetrahedral coordination geometries for cadmium are completed by chelating ligands. Copyright © 2004 John Wiley & Sons, Ltd.     

Crystal structure and photoluminescence properties of a new monomeric copper(II) complex: bis(3‐{[(3‐hydroxypropyl)imino]methyl}‐4‐nitrophenolato‐κ3O,N,O′)copper(II)

Copper(II)–Schiff base complexes have attracted extensive interest due to their structural, electronic, magnetic and luminescence properties. The title novel monomeric Cu^II complex, [Cu(C₁₀H₁₁N₂O₄)₂], has been synthesized by the reaction of 3‐{[(3‐hydroxypropyl)imino]methyl}‐4‐nitrophenol (H₂L ) and copper(II) acetate monohydrate in methanol, and was characterized by elemental analysis, UV and IR spectroscopies, single‐crystal X‐ray diffraction analysis and a photoluminescence study. The Cu^II atom is located on a centre of inversion and is coordinated by two imine N atoms, two phenoxy O atoms in a mutual trans disposition and two hydroxy O atoms in axial positions, forming an elongated octahedral geometry. In the crystal, intermolecular O—H…O hydrogen bonds link the molecules to form a one‐dimensional chain structure and π–π contacts also connect the molecules to form a three‐dimensional structure. The solid‐state photoluminescence properties of the complex and free H₂L have been investigated at room temperature in the visible region. When the complex and H₂L are excited under UV light at 349 nm, the complex displays a strong green emission at 520 nm and H₂L displays a blue emission at 480 nm.     

Triclinic and monoclinic polymorphs of meso‐(E,E)‐1,1′‐[1,2‐bis(4‐chlorophenyl)ethane‐1,2‐diyl]bis(phenyldiazene): the high‐yield synthesis of an unexpected product,concomitant polymorphism and configurational disorder

Pyrazolidine‐3,5‐diones and their derivatives exhibit a wide range of biological activities. Seeking to explore the effect of combining a hydrocarbyl ring substituent, as present in sulfinpyrazone (used to treat gout), with a chlorinated aryl ring, as present in muzolimine (a diuretic), we explored the reaction between 1‐phenylpyrazolidine‐3,5‐dione and 4‐chlorobenzaldehyde under mildly basic conditions in the expectation of producing the simple condensation product 4‐(4‐chlorobenzylidene)‐1‐phenylpyrazolidine‐3,5‐dione. However, the reaction product proved to be meso‐(E,E)‐1,1′‐[1,2‐bis(4‐chlorophenyl)ethane‐1,2‐diyl]bis(phenyldiazene), C₂₆H₂₀Cl₂N₄, and a tentative mechanism is proposed. Crystallization from ethanol produces two concomitant polymorphs, i.e. a triclinic form, (I), in the space group P, and a monoclinic form, (II), in the space group C2/c. In both polymorphs, the molecules lie across centres of inversion, but in (II), the molecules are subject to whole‐molecule disorder equivalent to configurational disorder with occupancies of 0.6021 (19) and 0.3979 (19). There are no hydrogen bonds in the crystal structure of polymorph (I), but the molecules of polymorph (II) are linked by C—H...π(arene) hydrogen bonds into complex chains, which are further linked into sheets by C—H...N interactions.     

Three new quinuclidine‐based structures: second harmonic generation response for 1,2‐bis(1‐azoniabicyclo[2.2.2]octan‐3‐ylidene)hydrazine dichloride

The crystal structures of three quinuclidine‐based compounds, namely (1‐azabicyclo[2.2.2]octan‐3‐ylidene)hydrazine monohydrate, C₇H₁₃N₃·H₂O ( 1 ), 1,2‐bis(1‐azabicyclo[2.2.2]octan‐3‐ylidene)hydrazine, C₁₄H₂₂N₄ ( 2 ), and 1,2‐bis(1‐azoniabicyclo[2.2.2]octan‐3‐ylidene)hydrazine dichloride, C₁₄H₂₄N₄²⁺·2Cl^? ( 3 ), are reported. In the crystal structure of 1 , the quinuclidine‐substituted hydrazine and water molecules are linked through N—H…O and O—H…N hydrogen bonds, forming a two‐dimensional array. The compound crystallizes in the centrosymmetric space group P2₁/c. Compound 2 was refined in the space group Pccn and exhibits no hydrogen bonding. However, its hydrochloride form 3 crystallizes in the noncentrosymmetric space group Pc. It shows a three‐dimensional network structure via intermolecular hydrogen bonding (N—H…C and N/C—H…Cl). Compound 3 , with its acentric structure, shows strong second harmonic activity.     

Crystallographic report: Bis{µ‐[O‐cyclopentyl(4‐methoxyphenyl) dithiophosphonato]1κ:S,2κ:S‐[O‐cyclopentyl(4‐methoxyphenyl)dithiophosphonato]1κ2S,S′} dizinc(II)

The centrosymmetric [Zn₂{CH₃OC₆H₄P(OC₅H₉)S₂}₄], features an eight‐membered Zn₂S₄P₂ ring as a result of two bidentate bridging thiolate ligands; the remaining ligands are chelating. Copyright © 2005 John Wiley & Sons, Ltd.     

π‐stacking and C—X...D (X = H,NO2; D = O, π) interactions in the crystal network of both C—H...N and π‐stacked dimers of 1,2‐bis(4‐bromophenyl)‐1H‐benzimidazole and 2‐(4‐bromophenyl)‐1‐(4‐nitrophenyl)‐1H‐benzimidazole

Molecules of 1,2‐bis(4‐bromophenyl)‐1H‐benzimidazole, C₁₉H₁₂Br₂N₂, (I), and 2‐(4‐bromophenyl)‐1‐(4‐nitrophenyl)‐1H‐benzimidazole, C₁₉H₁₂BrN₃O₂, (II), are arranged in dimeric units through C—H...N and parallel‐displaced π‐stacking interactions favoured by the appropriate disposition of N‐ and C‐bonded phenyl rings with respect to the mean benzimidazole plane. The molecular packing of the dimers of (I) and (II) arises by the concurrence of a diverse set of weak intermolecular C—X...D (X = H, NO₂; D = O, π) interactions.     

Comparison of the structure of (E)‐2‐(2‐benzylidenehydrazinylidene)quinoxaline with those of its chloro‐ and bromobenzylidene analogues

(E)‐2‐(2‐Benzylidenehydrazinylidene)quinoxaline, C₁₅H₁₂N₄, crystallized with two molecules in the asymmetric unit. The structures of six halogen derivatives of this compound were also investigated: (E)‐2‐[2‐(2‐chlorobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁ClN₄; (E)‐2‐[2‐(3‐chlorobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁ClN₄; (E)‐2‐[2‐(4‐chlorobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁ClN₄; (E)‐2‐[2‐(2‐bromobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁BrN₄; (E)‐2‐[2‐(3‐bromobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁BrN₄; (E)‐2‐[2‐(4‐bromobenzylidene)hydrazinylidene]quinoxaline, C₁₅H₁₁BrN₄. The 3‐Cl and 3‐Br compounds are isomorphous, as are the 4‐Cl and 4‐Br compounds. In all of these compounds, it was found that the supramolecular structures are governed by similar predominant patterns, viz. strong intermolecular N—H...N(pyrazine) hydrogen bonds supplemented by weak C—H...N(pyrazine) hydrogen‐bond interactions in the 2‐ and 3‐halo compounds and by C—H...Cl/Br interactions in the 4‐halo compounds. In all compounds, there are π–π stacking interactions.